To characterize T cell immunity changes associated with early Alzheimer's disease (AD) pathology, highlighting their potential significance in disease progression.
Key Findings:
CD8+ TEMRA cells were more prevalent in blood and CSF of HCS+ and MCI+ participants compared to HCS−, suggesting a potential role in disease progression.
MCI+ individuals exhibited a pro-inflammatory gene profile in CD8+ TEMRA cells compared to HCS+, indicating altered immune responses.
Changes in CD4+ T cell populations included reduced pro-inflammatory CD4+ central and effector memory T cells in amyloid-positive groups, which may affect overall immune function.
Autoreactive CD4+ T cell responses to Aβ peptides were diminished in MCI+ participants, raising questions about immune tolerance in early AD.
Interpretation:
The findings suggest that T cell dynamics, particularly the expansion of CD8+ TEMRA cells and alterations in CD4+ T cells, may play a significant role in the early stages of AD pathology and could inform future therapeutic strategies aimed at modulating immune responses.
Limitations:
The study primarily focuses on early-stage AD, limiting insights into later stages and the full spectrum of immune involvement.
The sample size and diversity of cohorts may affect the generalizability of the findings, necessitating further validation in larger, more diverse populations.
Conclusion:
Understanding T lymphocyte dynamics in AD could lead to novel disease-modifying therapies targeting immune responses, emphasizing the need for further research in this area.
